- Home/In The News/Press
16
June2020
RELEASE
KRS Global Biotechnology Acquired By Cleveland Diabetes Care
World-Renowned Dr. Charles Richardson to lead the company’s expansion BOCA RATON, Fla., June 16, 2020 /PRNewswire/ — KRS Global Biotechnology, Inc., a market-leading registered and inspected 503B Human Outsourcing Facility, is under new ownership and management as of Q1 2020. Cleveland Diabetes Care, Inc. (CDC), a clinical-stage biopharmaceutical, gene therapy, and medical devices technologies company based in Boca Raton, Florida, acquired […]
27
October2016
RELEASE
KRS Global Biotechnology Named Finalist for the Manufacturers Association of Florida Manufacturer of the Year
KRS is once again honored to be nominated as the Manufacturer of the Year but the Manufacturers Association of Florida. Thank you to the judges but also to each and every employee who has made all of this possible. #krsbio for-immediate-release
11
May2016
RELEASE
KRS L-Asparaginase Used In Study
Use of compounded L-asparaginase became routine in veterinary oncology when manufacturing of Elspar® was discontinued in 2012. The objective of this study was to evaluate the safety of compounded L-asparaginase (CLASP, KRS Global Biotechnology, Boca Raton, FL, USA) in comparison with Elspar® (Lundbeck LLC, Deerfield, IL, USA).